Your email has been added to our waiting list and we will send an invite to you as soon as possible. Thank you for your patience.
In the meantime, if you happen to run a blog, our newly launched Blog Enhancement Suite can utilize the immense power of community to help you get more audience, engagement, content, and revenue with your own embeddable community! It will breathe new life into your blog and can automate many of the tedious tasks that come with the territory, so you can focus more on what matters most... writing.
Help spread the word about Snapzu:
Let others know about Snapzu by tweeting about us. We appreciate every mention!
New discovery could slow Alzheimer’s in its tracks
A new breakthrough is offering hope to people living with Alzheimer’s disease and their families. Praveen Nekkar, a professor at the University of Waterloo School of Pharmacy, has discovered that two common medications for depression and mood disorders — fluoxetine and paroxetine — have the potential to slow the advancement of Alzheimer’s disease and dementia. The finding, published in the journal ACS Chemical Neuroscience, is significant because it could be the key to preventing and ultimately curing the disease. It could not come at a more critical time, as the numbers of those living with Alzheimer’s disease reach epidemic proportions.